Table 2.
Performance of different methods assorted due to EORTC/MSG classification
| EORTC/MSG classification (n)a | IHE-PF |
IHE-HHQ |
UCP-PF |
UCP-HHQ |
No. of serum GM positive-patients (%) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of detected patients (%) | No. of positive PCR specimens by result type b |
No. of detected patients (%) | No. of positive PCR specimens by result type |
No. of detected patients (%) | No. of positive PCR specimens by result type |
No. of detected patients (%) | No. of positive PCR specimens by result type |
||||||||||
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | ||||||
| Probable IA (3) | 2 (66.7) | 3 | 1 | 1 (33.3) | 1 | 1 | 3 (100.0) | 5 | 3 (100.0) | 1 | 5 | 2 (66.7) | |||||
| Possible IA (18) | 3 (16.7) | 2 | 1 | 4 (22.2) | 4 | 1 | 8 (44.4) | 5 | 2 | 2 | 8 (44.4) | 6 | 2 | 4 | 0 (0) | ||
| Unclassified (41) | 5 (12.2) | 5 | 8 (19.5) | 9 | 13 (31.7) | 12 | 3 | 7 (17.1) | 7 | 2 | 0 (0) | ||||||
a
n, number of patients.
b
For triplicate PCRs, result types are indicated as follows: 1, single positive replicate; 2, two positive replicates; 3, three positive replicates.